However, higher circulating levels of CCL5 were not significantly associated with other inflammatory variables and metabolic parameters, suggesting more studies are required to evaluate the novel hypothesis that CCL5 is a risk factor for T2DM. This evidence concerns the gene CCL5 and type 2 diabetes mellitus.